Nabilone | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | |
Nabilone | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.11E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | |
Nabilone | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 8.72E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | |
Nabilone | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | |
Nabilone | hsa00670 | One carbon pool by folate | 1.33E-02 | 2 | P04818, Q99707 | TYMS, MTR | More | |
Nabilone | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | |
Nabilone | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa01522 | Endocrine resistance | 1.69E-02 | 4 | P22694, P08069, P10415, Q13323 | PRKACB, IGF1R, BCL2, BIK | More | |
Nabilone | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | |
Nabilone | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | |
Nabilone | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04012 | ErbB signaling pathway | 1.91E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | |
Nabilone | hsa04014 | Ras signaling pathway | 1.13E-02 | 9 | P42338, P20827, P49767, P08069, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, IGF1R, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | |
Nabilone | hsa04015 | Rap1 signaling pathway | 5.95E-03 | 9 | P20827, P49767, P08069, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, IGF1R, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | |
Nabilone | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | |
Nabilone | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04070 | Phosphatidylinositol signaling system | 2.96E-02 | 3 | P19174, P49619, P27987 | PLCG1, DGKG, ITPKB | More | |
Nabilone | hsa04080 | Neuroactive ligand-receptor interaction | 4.90E-03 | 6 | P08311, Q15722, P21453, Q9H228, O00398, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, ADRB2 | More | |
Nabilone | hsa04110 | Cell cycle | 1.72E-03 | 7 | Q9UBD5, P06493, Q14683, P30304, P33981, P01106, Q13547 | ORC3, CDK1, SMC1A, CDC25A, TTK, MYC, HDAC1 | More | |
Nabilone | hsa04114 | Oocyte meiosis | 1.45E-04 | 6 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0, P08069 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | |
Nabilone | hsa04140 | Autophagy - animal | 2.81E-02 | 4 | P08069, P22694, Q14643, P10415 | IGF1R, PRKACB, ITPR1, BCL2 | More | |
Nabilone | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | |
Nabilone | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04211 | Longevity regulating pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04213 | Longevity regulating pathway - multiple species | 1.66E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04340 | Hedgehog signaling pathway | 9.74E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
Nabilone | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | |
Nabilone | hsa04370 | VEGF signaling pathway | 9.46E-05 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
Nabilone | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | |
Nabilone | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | |
Nabilone | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04540 | Gap junction | 2.86E-02 | 3 | P22694, P68371, Q14643 | PRKACB, TUBB2C, ITPR1 | More | |
Nabilone | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 9.61E-03 | 4 | Q13873, Q02750, P08069, Q86SE9 | BMPR2, MAP2K1, IGF1R, PCGF5 | More | |
Nabilone | hsa04613 | Neutrophil extracellular trap formation | 1.56E-02 | 5 | P19174, P11215, Q13547, P62807, Q16778 | PLCG1, ITGAM, HDAC1, HIST1H2BC, HIST2H2BE | More | |
Nabilone | hsa04630 | JAK-STAT signaling pathway | 3.20E-02 | 4 | P01106, P42224, P14784, Q13651 | MYC, STAT1, IL2RB, IL10RA | More | |
Nabilone | hsa04650 | Natural killer cell mediated cytotoxicity | 3.73E-02 | 3 | P16298, P50591, Q02750 | PPP3CB, TNFSF10, MAP2K1 | More | |
Nabilone | hsa04658 | Th1 and Th2 cell differentiation | 1.48E-04 | 6 | P07766, P19174, P06239, P42224, P14784, Q13761 | CD3E, PLCG1, LCK, STAT1, IL2RB, RUNX3 | More | |
Nabilone | hsa04659 | Th17 cell differentiation | 3.55E-04 | 9 | P19174, P06239, P42224, P14784, P14778, P84022, Q13485, P08238, P07766 | PLCG1, LCK, STAT1, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E | More | |
Nabilone | hsa04662 | B cell receptor signaling pathway | 1.74E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | |
Nabilone | hsa04664 | Fc epsilon RI signaling pathway | 2.47E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | |
Nabilone | hsa04720 | Long-term potentiation | 2.85E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | |
Nabilone | hsa04725 | Cholinergic synapse | 3.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | |
Nabilone | hsa04730 | Long-term depression | 1.16E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa04913 | Ovarian steroidogenesis | 8.54E-03 | 3 | P42330, P22694, P08069 | AKR1C3, PRKACB, IGF1R | More | |
Nabilone | hsa04914 | Progesterone-mediated oocyte maturation | 2.23E-04 | 5 | P08069, Q17RY0, Q9Y6D9, P51812, Q02750 | IGF1R, CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | |
Nabilone | hsa04919 | Thyroid hormone signaling pathway | 1.64E-02 | 4 | P19174, P42224, Q13547, P01106 | PLCG1, STAT1, HDAC1, MYC | More | |
Nabilone | hsa04924 | Renin secretion | 3.09E-03 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
Nabilone | hsa04927 | Cortisol synthesis and secretion | 2.72E-02 | 2 | Q14643, P22694 | ITPR1, PRKACB | More | |
Nabilone | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.02E-02 | 4 | Q14643, P22694, P23771, P10415 | ITPR1, PRKACB, GATA3, BCL2 | More | |
Nabilone | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | |
Nabilone | hsa04934 | Cushing syndrome | 4.74E-02 | 3 | Q14643, P22694, P04628 | ITPR1, PRKACB, WNT1 | More | |
Nabilone | hsa04970 | Salivary secretion | 2.11E-02 | 3 | P07550, P22694, Q14643 | ADRB2, PRKACB, ITPR1 | More | |
Nabilone | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.95E-02 | 2 | Q06055, O15020 | ATP5G2, SPTBN2 | More | |
Nabilone | hsa05034 | Alcoholism | 4.79E-02 | 3 | Q13547, P62807, Q16778 | HDAC1, HIST1H2BC, HIST2H2BE | More | |
Nabilone | hsa05100 | Bacterial invasion of epithelial cells | 2.85E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | |
Nabilone | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
Nabilone | hsa05169 | Epstein-Barr virus infection | 3.66E-02 | 5 | P01106, Q13547, Q13761, P42224, P07766 | MYC, HDAC1, RUNX3, STAT1, CD3E | More | |
Nabilone | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | |
Nabilone | hsa05202 | Transcriptional misregulation in cancer | 2.82E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa05203 | Viral carcinogenesis | 9.16E-03 | 5 | Q13547, P12814, P06493, P62807, Q16778 | HDAC1, ACTN1, CDK1, HIST1H2BC, HIST2H2BE | More | |
Nabilone | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | |
Nabilone | hsa05214 | Glioma | 9.95E-03 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | |
Nabilone | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | |
Nabilone | hsa05231 | Choline metabolism in cancer | 8.99E-04 | 3 | Q9Y259, P19174, P49619 | CHKB, PLCG1, DGKG | More | |
Nabilone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.46E-03 | 5 | P19174, P07766, P06239, P42224, Q9HC35 | PLCG1, CD3E, LCK, STAT1, EML4 | More | |
Nabilone | hsa05322 | Systemic lupus erythematosus | 2.75E-02 | 3 | P62807, Q16778, P12814 | HIST1H2BC, HIST2H2BE, ACTN1 | More | |